Trials / Recruiting
RecruitingNCT06607445
Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service.
Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service. Population Cohort [MedeA21].
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,445 (estimated)
- Sponsor
- Complejo Hospitalario Universitario de Badajoz · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
An open longitudinal observational study, non-randomized, which will include the adult population, attended by the SES, in which preference will be given to those patients under treatment with drugs that can produce relevant adverse effects. It is a naturalistic study in which no pharmacological or other type of intervention will be carried out, only the information recommended in the drug data sheet (pharmacogenetic biomarkers, relevant interactions and clinical contraindications) will be provided.
Conditions
Timeline
- Start date
- 2021-05-26
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2024-09-23
- Last updated
- 2024-09-23
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06607445. Inclusion in this directory is not an endorsement.